OptimizeRx

Leading point-of-care digital engagement platform for life sciences brands targeting healthcare providers within EHR and clinical workflow environments

OptimizeRx operates a digital health platform that enables pharmaceutical and biotech companies to reach healthcare providers (HCPs) at the point of care — directly within electronic health record (EHR) systems and other clinical workflow tools. By embedding communications into the clinical workflow, OptimizeRx allows life sciences marketers to deliver branded and unbranded messaging, patient support resources, financial assistance information, and clinical education to physicians at the moment of prescribing decisions. This makes it a specialized marketing and communications platform serving the pharma and life sciences sector. The company's core product, the DAAP (Dynamic Audience Activation Platform), leverages real-world data and AI to identify and target the right HCPs with relevant messages at the right time. OptimizeRx partners with a broad network of EHR vendors and clinical platforms to reach a significant portion of the U.S. physician population, giving it a differentiated position in the HCP-targeted marketing space. Its clients are primarily pharmaceutical manufacturers seeking compliant, efficient ways to engage prescribers. OptimizeRx is publicly traded on the Nasdaq and has established itself as a leading player in the HCP digital engagement and point-of-care marketing segment. It competes with companies like Doceree, Veeva Systems, and other HCP-focused digital media and data platforms. The company's revenue is primarily generated through program fees from life sciences clients for running digital engagement campaigns through its network.